Icon Advisers Inc Amneal Pharmaceuticals, Inc. Transaction History

Icon Advisers Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$2.29 - $7.1 $293,216 - $909,098	-128,042 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$11.87 - $14.84 $447,498 - $559,468	-37,700 Reduced 22.75%	128,042 $1.81 Million
Q4 2018 Feb 04, 2019	BUY	$13.09 - $21.49 $1.74 Million - $2.86 Million	133,242 Added 409.98%	165,742 $2.24 Million
Q3 2018 Nov 05, 2018	SELL	$16.4 - $24.27 $478,879 - $708,684	-29,200 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$13.95 - $20.2 $407,340 - $589,840	29,200 New	29,200 $479,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Icon Advisers Inc with notifications on news.